Cardiff Oncology confirms no exposure to Silicon Valley Bank

Cardiff Oncology, Inc.

Company issued 8-K confirming it holds no cash deposits or securities at SVB.
Disclosure made on March 10, 2023 amid SVB collapse concerns.
No financial impact or loss from the bank failure.
Ticker CRDF traded on Nasdaq; no change to operations or cash position.

item 7.01

Cardiff Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-007567

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.